Fractyl Health, Inc. - Common Stock (NQ:GUTS)

0.7049 -0.0051 (-0.72%)

Streaming Delayed Price Updated: 11:15 AM EDT, Sep 1, 2026 Add to My Watchlist

Price and Volume

Volume	391,991
Open	0.6900
Bid (Size)	0.7049 (100)
Ask (Size)	0.7059 (1,800)
Prev. Close	0.7100
Today's Range	0.6854 - 0.7141
52wk Range	0.3772 - 2.445
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Deadline Soon: Fractyl Health, Inc. (GUTS) Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit

August 31, 2026

From The Law Offices of Frank R. Cruz

Via Business Wire

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 20, 2026 in Fractyl Health, Inc. Lawsuit - GUTS

August 28, 2026

From Levi & Korsinsky, LLP

Via Business Wire

Performance

YTD	-68.7%	-68.7%
1 Month	+4.1%	+4.1%
3 Month	-18.7%	-18.7%
6 Month	+40.4%	+40.4%
1 Year	-27.8%	-27.8%

More News

Law Offices of Howard G. Smith Encourages Fractyl Health, Inc. (GUTS) Shareholders To Inquire About Securities Fraud Class Action

August 27, 2026

From Law Offices of Howard G. Smith

Via Business Wire

Fractyl Health Inc (NASDAQ:GUTS) Q1 Earnings: Net Income Swing Masks Core Operating Burn as Key Revita Data Readout Looms ↗

May 12, 2026

Via Chartmill

Law Offices of Frank R. Cruz Encourages Fractyl Health, Inc. (GUTS) Shareholders to Inquire About Securities Fraud Class Action

August 26, 2026

From Law Offices of Frank R. Cruz

Via Business Wire

Securities Fraud Investigation Into Fractyl Health, Inc. (GUTS) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

August 26, 2026

From Glancy Prongay Wolke & Rotter LLP

Via Business Wire

Faruqi & Faruqi, LLP Urges Fractyl Health, Inc. (NASDAQ: GUTS) Investors to Seek Counsel Before the October 20, 2026 Lead Plaintiff Deadline in the Securities Class Action

August 26, 2026

From Faruqi & Faruqi, LLP

Via Business Wire

Fractyl Health, Inc. (GUTS) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

August 26, 2026

From Law Offices of Howard G. Smith

Via Business Wire

Securities Fraud Investigation Into Fractyl Health, Inc. (GUTS) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

August 25, 2026

From The Law Offices of Frank R. Cruz

Via Business Wire

Stockholder Alert: Robbins LLP Informs Investors of the Fractyl Health, Inc. Class Action

August 21, 2026

From Robbins LLP

Via Business Wire

Fractyl Health to Host Virtual Commercial Strategy Day on Tuesday, September 1, 2026: The Potential Path to Commercializing Revita®, a Procedural Therapy for Post-GLP-1 Weight Maintenance

August 20, 2026

From Fractyl Health, Inc.

Via GlobeNewswire

Fractyl Health Eyes Q4 Revita Data, Launches Rejuva Gene Therapy Trial ↗

August 14, 2026

Via MarketBeat

Fractyl Health Q2 Earnings Call Highlights ↗

August 10, 2026

Via MarketBeat

Fractyl Health Reports Second Quarter 2026 Financial Results and Business Updates

August 10, 2026

From Fractyl Health, Inc.

Via GlobeNewswire

Fractyl Health to Report Second Quarter 2026 Financial Results and Provide Business Updates on August 10, 2026

August 03, 2026

From Fractyl Health, Inc.

Via GlobeNewswire

Fractyl Health to Participate in Upcoming Investor Events

July 22, 2026

From Fractyl Health, Inc.

Via GlobeNewswire

These stocks are moving in today's session ↗

July 15, 2026

Via Chartmill

Fractyl Health Says Revita Helped Patients Keep Weight Off After Stopping GLP-1s ↗

July 15, 2026

Via MarketBeat

Fractyl Health Reports Positive Randomized Data from REMAIN-1 Midpoint Cohort Demonstrating Durable Weight Maintenance One Year After GLP-1 Discontinuation

July 15, 2026

From Fractyl Health, Inc.

Via GlobeNewswire

Fractyl Health Reports Positive One-Year REVEAL-1 Open-Label Results Showing Sustained Post-GLP-1 Weight Maintenance After a Single Revita® Procedure

June 04, 2026

From Fractyl Health, Inc.

Via GlobeNewswire

Fractyl Health Appoints Mike Zumdahl as Senior Vice President, Market Access and Commercial Strategy

June 01, 2026

From Fractyl Health, Inc.

Via GlobeNewswire

Fractyl Health Q1 Earnings Call Highlights ↗

May 12, 2026

Via MarketBeat

Fractyl Health Reports First Quarter 2026 Financial Results and Business Updates

May 12, 2026

From Fractyl Health, Inc.

Via GlobeNewswire

Fractyl Health Authorized to Initiate First-in-Human Trial of RJVA-001 in the Netherlands: First Gene Therapy Candidate to Enter Clinical Development for Type 2 Diabetes

May 11, 2026

From Fractyl Health, Inc.

Via GlobeNewswire

Fractyl Health to Report First Quarter 2026 Financial Results and Provide Business Updates on May 12, 2026, and Will Participate in an Upcoming Investor Conference

May 05, 2026

From Fractyl Health, Inc.

Via GlobeNewswire

Frequently Asked Questions

Is Fractyl Health, Inc. - Common Stock publicly traded?

Yes, Fractyl Health, Inc. - Common Stock is publicly traded.

What exchange does Fractyl Health, Inc. - Common Stock trade on?

Fractyl Health, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Fractyl Health, Inc. - Common Stock?

The ticker symbol for Fractyl Health, Inc. - Common Stock is GUTS on the Nasdaq Stock Market

What is the current price of Fractyl Health, Inc. - Common Stock?

The current price of Fractyl Health, Inc. - Common Stock is 0.7049

When was Fractyl Health, Inc. - Common Stock last traded?

The last trade of Fractyl Health, Inc. - Common Stock was at 09/01/26 11:15 AM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

About Us

Fractyl Health, Inc. - Common Stock (NQ:GUTS)

Price and Volume

Top News

Performance

More News

Frequently Asked Questions